2021 American Transplant Congress » Kidney Immunosuppression

6:00pm-6:05pm

A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of At-1501

S. Perrin¹, A. Gill², C. Gill², P. Gustafson¹

6:05pm-6:10pm

Evaluation of a Weight-Based Mycophenolate Mofetil Dosing Protocol for Kidney Transplant Maintenance Immunosuppression

M. Mahoney¹, E. Kincaide¹, J. Nelson¹, K. Klein¹, R. Hall¹, S. Bhayana²

6:10pm-6:15pm

The Clinical Validation of a Dried Blood Spot Method for Simultaneous Tacrolimus and Creatinine Measurement

M. I. Francke¹, S. Bouarfa², B. van Domburg², D. van de Velde², M. E. Hellemons³, O. C. Manintveld⁴, S. M. Last-Koopmans⁵, M. B. Mulder², D. A. Hesselink¹, B. C. de Winter²

6:15pm-6:20pm

CD40 Blockade by the Fc-Silent Immunosuppressive Antibody Iscalimab Results in Diminished B Cell Activation and Differentiation and is Paralleled by Whole Blood Gene Expression Data

R. Kraaijeveld¹, M. W. van den Hoogen¹, A. E. de Weerd¹, E. Ferroro², G. Robert², U. Laessing², B. Haraldsson², J. S. Rush², C. C. Baan¹

6:20pm-6:25pm

Conversion to Belatacept Based Immunosuppression Regimen in Kidney Transplant Patients: Lessons Learned

R. Saidi, N. Huang, C. Yang, I. Movileanu, K. Ecal, A. Senay, O. Pankewycz, R. Dvorai, R. Shahbazov, M. Laftavi

6:25pm-6:30pm

Immunosuppression and Cancer Risk in Kidney Transplant Recipients: A Retrospective Cohort Study

R. Sapir-Pichhadze¹, C. Laprise¹, X. Zhang¹, M. Abrahamowicz¹, M. Beauchamp², A. Della Vecchia¹, L. Azoulay¹, E. Franco¹, B. Nicolau¹

6:30pm-6:35pm

Clinical Outcomes Associated with Induction Therapy Regimens for Kidney Transplantation in Children: A NAPRTCS and PHIS Collaborative Report

H. Pizzo¹, D. Levy Erez², N. M. Rodig³, T. Richardson⁴, M. Somers³

6:35pm-6:40pm

Single-Dose Basiliximab Induction Therapy in Low-Immunologic Risk Kidney Transplant Recipients

A. Hutchins, J. Schoen, J. S. McMullen